MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Pshychoeducational interventions for demented patients with parkinsonism and their families

    P.N.S. Almeida, A.C.P. Koutsandréou, A.C.M. Neri (Salvador, Brazil)

    Objective: Introduce a neuropsychological rehabilitation program, based on a combination of techniques' strategy, such as Reality Orientation Therapy, Reminiscence Therapy, Memory Rehabilitation, Cognitive Training, Ecological…
  • 2016 International Congress

    Moist smokeless tobacco (Snus) use and risk of Parkinson’s disease: Meta-analysis of individual participant data from seven prospective observational studies

    F. Yang, N.L. Pedersen, W. Ye, Z. Liu, M. Norberg, L. Forsgren, Y. Trolle Lagerros, R. Bellocco, L. Alfredsson, A. Knutsson, J.H. Jansson, R. Galanti, A.C.J. Lager, M. Araghi, M. Lundberg, C. Magnusson, K. Wirdefeldt (Stockholm, Sweden)

    Objective: To investigate the associations between use of Swedish moist smokeless tobacco (snus) and risk of Parkinson's disease (PD). Background: Cigarette smoking is associated with…
  • 2016 International Congress

    Dynamics in statin use, low density lipoprotein cholesterol levels and Parkinson’s disease. A population-based cohort study using big-data

    V. Rozani, N. Giladi, B. Elad, T. Gurevich, J. Tsamir, B. Hemo, C. Peretz (Petach Tikva, Israel)

    Objective: To evaluate the association between time-varying statin use and PD risk in a large-scale population-based study. Background: Statins have been shown to downregulate neuroinflammation,…
  • 2016 International Congress

    Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease

    M. Salari, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)

    Objective: To evaluate prevalence of nanometer symptoms in patients with Parkinson's disease. Background: While PD (Parkinson's disease) is diagnosed on the basis of motor symptoms,…
  • 2016 International Congress

    Cardiovascular and cerebrovascular disorders are associated with a higher prevalence of parkinsonism: Data from a neuroepidemiologic community-based survey

    S.M. Fereshtehnejad, M. Shafieisabet, A. Rahmani, A. Delbari, J. Lökk (Stockholm, Sweden)

    Objective: To evaluate the association between comorbidity profile (consisting of the cardiovascular and cerebrovascular diseases) and the prevalence of parkinsonism using data from a neuroepidemiologic…
  • 2016 International Congress

    Prevalence of Parkinson’s disease and myotonic dystrophy in the nomadic population: Mongolian study

    T. Sosorburam, B. Samdan, J. Amar (Ulan-Bator, Mongolia)

    Objective: To determine the prevalence of Parkinson's disease (PD) and Myotonic Dystrophy (MD) in the isolated people, where a study never been conducted before regarding…
  • 2016 International Congress

    Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

    L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)

    Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…
  • 2016 International Congress

    Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV

    N. Prinz, L. Wang, J. Stingl, M.D. Denkinger, P. Fasching, P.M. Jehle, S. Merger, S. Mühldorfer, A. Schuler, A. Zeyfang, M. Sharma, R.W. Holl (Ulm, Germany)

    Objective: To study the presence of dementia in older people with Type 2 diabetes mellitus (T2DM) and to compare demographics with non-demented T2DM patients. Background:…
  • 2016 International Congress

    Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1

    A. Perez, A.M. Wills, J. Wang, X. Su, J. Morgan, S.S. Rajan, M. Leehey, G.M. Pontone, K.L. Chou, C. Umeh, Z. Mari, J. Boyd, For the NINDS NET-PD Investigators (Austin, TX, USA)

    Objective: To report the statistical analyses exploring the association between BMI and change in Unified Parkinson's disease Rating Scale (UPDRS) scores and survival in the…
  • 2016 International Congress

    Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?

    F. Escamilla-Sevilla, J. Pinel-Ríos, C.J. Madrid-Navarro, R. Piñar-Morales, J.D. Herrera-García, M.J. Pérez-Navarro, C. Del Canto-Pérez, M.J. Cabello-Tapia, M.d.m. Martín-Rodríguez, D. Sánchez-Capilla, M.J. Piña-Vera, A. Aguilar-Muñoz, V. Campos-Arillo, J. Gutiérrez-García, C.E. Chamorro-Santos, M.R. Gómez-García, A. Mínguez-Castellanos (Granada, Spain)

    Objective: To analyze the association between aminosalicylate-treated inflammatory bowel disease (IBD-A) and Parkinson´s disease (PD) at population level. Background: According to the dual-hit hypothesis, the…
  • « Previous Page
  • 1
  • …
  • 1775
  • 1776
  • 1777
  • 1778
  • 1779
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley